Unavailable
Unavailable
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 4/15/2025 | $224.00 | Outperform → Neutral | Robert W. Baird |
| 3/26/2025 | $200.00 | Equal-Weight | Morgan Stanley |
| 2/3/2025 | Neutral → Overweight | Cantor Fitzgerald | |
| 12/17/2024 | $226.00 | Neutral | Analyst |
| 12/16/2024 | $228.00 → $198.00 | Buy → Neutral | Goldman |
| 11/6/2024 | $223.00 | Neutral | BofA Securities |
| 10/16/2024 | $220.00 → $283.00 | Hold → Buy | TD Cowen |
| 10/11/2024 | Sector Weight | KeyBanc Capital Markets |
KING OF PRUSSIA, Pa., Oct. 25, 2022 /PRNewswire/ -- Universal Health Services, Inc. (NYSE:UHS) has announced the appointment of Edward (Eddie) H. Sim to Executive Vice President and President, Acute Care, succeeding Marvin Pember, who has announced his intention to retire. Reporting to President and CEO Marc D. Miller, Eddie will drive strategy and operations across the UHS Acute Care portfolio including UHS' Acute Care hospitals, freestanding emergency departments (FEDs) and ambulatory centers, as well as Independence Physician Management and Prominence Health Plan. "We thank Marvin for his service to UHS," said Marc D. Miller, President and CEO, UHS. "Under Marvin's leadership over the pas
Robert W. Baird downgraded Universal Health from Outperform to Neutral and set a new price target of $224.00
Morgan Stanley initiated coverage of Universal Health with a rating of Equal-Weight and set a new price target of $200.00
Cantor Fitzgerald upgraded Universal Health from Neutral to Overweight
4 - UNIVERSAL HEALTH SERVICES INC (0000352915) (Issuer)
4 - UNIVERSAL HEALTH SERVICES INC (0000352915) (Issuer)
4 - UNIVERSAL HEALTH SERVICES INC (0000352915) (Issuer)
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended March 31, 2025 and 2024: KING OF PRUSSIA, Pa., April 28, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $316.7 million, or $4.80 per diluted share, during the first quarter of 2025, as compared to $261.8 million, or $3.82 per diluted share, during the first quarter of 2024. Net revenues increased by 6.7% to $4.100 billion during the first quarter of 2025, as compared to $3.844 billion during the first quarter of 2024. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our
Intends to File Preliminary Proxy Statement and Provides Overview of the Case for Shareholder-Driven Change at Lyft Following Years of Value Destruction Engine Capital LP (together with its affiliates, "Engine" or "we"), which owns approximately one percent of the outstanding common shares of Lyft, Inc. (NASDAQ:LYFT) ("Lyft" or the "Company"), today announced that it is filing a preliminary proxy statement in connection with its nomination of two highly qualified and independent candidates – Alan L. Bazaar and Daniel B. Silvers – for election to the Company's Board of Directors (the "Board") at the 2025 Annual Meeting of Shareholders (the "Annual Meeting"). Arnaud Ajdler, Founder and Port
KING OF PRUSSIA, Pa., April 9, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2025, after the market closes on Monday, April 28, 2025. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Tuesday, April 29, 2025 A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registran
SC 13G/A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Subject)
SC 13G/A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Subject)
SC 13G/A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Subject)
10-Q - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)
8-K - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)
DEFA14A - UNIVERSAL HEALTH SERVICES INC (0000352915) (Filer)
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended March 31, 2025 and 2024: KING OF PRUSSIA, Pa., April 28, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $316.7 million, or $4.80 per diluted share, during the first quarter of 2025, as compared to $261.8 million, or $3.82 per diluted share, during the first quarter of 2024. Net revenues increased by 6.7% to $4.100 billion during the first quarter of 2025, as compared to $3.844 billion during the first quarter of 2024. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"), our
KING OF PRUSSIA, Pa., April 9, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that it will report results for its first quarter ended March 31, 2025, after the market closes on Monday, April 28, 2025. There will be a conference call for investors and analysts at 9:00 a.m. Eastern time on Tuesday, April 29, 2025 A live webcast of the call will be available on the company's website at www.uhs.com. To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registran
Consolidated Results of Operations, As Reported and As Adjusted – Three-month periods ended December 31, 2024 and 2023: KING OF PRUSSIA, Pa., Feb. 26, 2025 /PRNewswire/ -- Universal Health Services, Inc. (NYSE: UHS) announced today that its reported net income attributable to UHS was $332.4 million, or $4.96 per diluted share, during the fourth quarter of 2024, as compared to $216.4 million, or $3.16 per diluted share, during the fourth quarter of 2023. Net revenues increased by 11.1% to $4.114 billion during the fourth quarter of 2024, as compared to $3.704 billion during the fourth quarter of 2023. As reflected on the Schedule of Non-GAAP Supplemental Information ("Supplemental Schedule"